Biotech Values

[DewDiligence]

>I read the valuation links. They have links to other companies, but no messages comparing valuations of GTCB with other companies. What am I missing?<

Pharming is GTC’s most applicable comparator inasmuch as the companies have similar business models and cross-licensed IP. #msg-17760532, although out of date, addresses the relative valuations of Pharming and GTC as of the date it was written (early 2007).

>I did read ReadMeFirst, but it does not answer some of my questions<

Your other questions are either unanswerable (e.g. “What do others think?” ) or are matters of opinion that can be derived from the contents of the RMF with a modicum of effort. Regards, Dew



Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”